Bringing the fundamentals into focus…
Back to The Oncology Institute, Inc.
How The Oncology Institute, Inc. stacks up
STLN · against 454 other Healthcare companies listed in US-listed
Growth
79/ 100
Above the middle of the pack.
Ranked #152 of 455 · scores higher than 66% of peers
Bars: peers in each 10-point band of the growth score52 peers with a growth score of 70–79, including STLN · Click a bar to see the companies
Why growth scores 79?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its revenue growth and 3-year revenue growth, which are stronger than most Healthcare peers.
- slower growth in earnings per share: weaker than 73% of peers. Earnings per share growth: -14.0% vs peer median 9.8%
- faster revenue growth over three years: stronger than 86% of peers. 3-year revenue growth: 26.1% vs peer median 5.8%
- faster revenue growth over the last year: stronger than 88% of peers. Revenue growth: 38.4% vs peer median 6.1%
Metric by metric
Position: dot = STLN, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | STLN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 475 reported | 38.4% | 11.0% | 79% | 33% | |
| Earnings per share growthHigher is better · 171 reported | -14.0% | 21.2% | 21% | 33% | |
| 3-year revenue growthHigher is better · 433 reported | 26.1% | 11.0% | 74% | 33% |
Ranking by growth score
Top 5 and the companies ranked around STLN| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 8.8B USD | 99 | 31 | |
| 2 | 90M USD | 99 | 27 | |
| 152 | 13.7B USD | 79 | 45 | |
| 152 | 5.8B USD | 79 | 64 | |
| 152 | 1.5B USD | 79 | 43 | |
| 152 | 374M USD | 79 | 66 | |
| 152 | 646M USD | 79 | 46 | |
| 158 | 1.8B USD | 78 | 63 | |
| 158 | 457M USD | 78 | 58 | |
| 158 | 8.7B USD | 78 | 26 | |
| 158 | 31.3B USD | 78 | 63 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score